Neutralization of multiple laboratory and clinical isolates of human immunodeficiency virus type 1 (HIV-1) by antisera raised against gp120 from the MN isolate of HIV-1.
Vaccines prepared from the envelope glycoprotein, gp120, of the common laboratory isolate of human immunodeficiency virus type 1 (HIV-1) (IIIB/LAV-1) elicit antibodies that neutralize the homologous virus but show little if any cross-neutralizing activity. This may be because the principal neutraliz...
Shranjeno v:
| izdano v: | J Virol |
|---|---|
| Principais autores: | , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1992
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC241255/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1602554/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.66.7.4464-4469.1992 |
| Oznake: |
Brez oznak, prvi označite!
|
